Sonoma Pharmaceuticals Inc. [NASDAQ: SNOA] traded at a low on Wednesday, posting a -8.45 loss after which it closed the day’ session at $0.22.
The results of the trading session contributed to over 18236238 shares changing hands. Over the past one week, the price volatility of Sonoma Pharmaceuticals Inc. stands at 14.44% while the volatility over the past one month is 17.16%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for SNOA stock reached $4.22 million, with 19.00 million shares outstanding and 18.59 million shares in the current float. Compared to the average trading volume of 4.68M shares, SNOA reached a trading volume of 18236238 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Sonoma Pharmaceuticals Inc. [SNOA]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SNOA shares is $1.30 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SNOA stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Sonoma Pharmaceuticals Inc. is set at 0.05, with the Price to Sales ratio for SNOA stock in the period of the last 12 months amounting to 0.33. The Price to Book ratio for the last quarter was 0.85, with the Price to Cash per share for the same quarter was set at 0.14.
How has SNOA stock performed recently?
Sonoma Pharmaceuticals Inc. [SNOA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -5.81. With this latest performance, SNOA shares dropped by -40.74% in over the last four-week period, additionally plugging by 43.85% over the last 6 months – not to mention a drop of -73.87% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SNOA stock in for the last two-week period is set at 40.93, with the RSI for the last a single of trading hit 36.24, and the three-weeks RSI is set at 44.09 for Sonoma Pharmaceuticals Inc. [SNOA]. The present Moving Average for the last 50 days of trading for this stock 0.2796, while it was recorded at 0.2419 for the last single week of trading, and 0.1962 for the last 200 days.
Sonoma Pharmaceuticals Inc. [SNOA]: Deeper insight into the fundamentals
Sonoma Pharmaceuticals Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.41 and a Current Ratio set at 3.12.
Insider trade positions for Sonoma Pharmaceuticals Inc. [SNOA]
There are presently around $2.29%, or 2.34%% of SNOA stock, in the hands of institutional investors. The top three institutional holders of SNOA stocks are: CITADEL ADVISORS LLC with ownership of 0.2 million shares, which is approximately 1.2504%. GEODE CAPITAL MANAGEMENT, LLC, holding 86644.0 shares of the stock with an approximate value of $$18385.0 in SNOA stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $$9611.0 in SNOA stock with ownership which is approximately 0.2902%.
